These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 30413658)

  • 1. Metabolic Subtyping of Pheochromocytoma and Paraganglioma by
    van Berkel A; Vriens D; Visser EP; Janssen MJR; Gotthardt M; Hermus ARMM; Geus-Oei LF; Timmers HJLM
    J Nucl Med; 2019 Jun; 60(6):745-751. PubMed ID: 30413658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma.
    van Berkel A; Rao JU; Kusters B; Demir T; Visser E; Mensenkamp AR; van der Laak JA; Oosterwijk E; Lenders JW; Sweep FC; Wevers RA; Hermus AR; Langenhuijsen JF; Kunst DP; Pacak K; Gotthardt M; Timmers HJ
    J Nucl Med; 2014 Aug; 55(8):1253-9. PubMed ID: 24925884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
    Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K
    J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Noortman WA; Vriens D; de Geus-Oei LF; Slump CH; Aarntzen EH; van Berkel A; Timmers HJLM; van Velden FHP
    Eur Radiol; 2022 Oct; 32(10):7227-7236. PubMed ID: 36001126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superiority of
    Jha A; Ling A; Millo C; Gupta G; Viana B; Lin FI; Herscovitch P; Adams KT; Taïeb D; Metwalli AR; Linehan WM; Brofferio A; Stratakis CA; Kebebew E; Lodish M; Civelek AC; Pacak K
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):787-797. PubMed ID: 29204718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature?
    Taïeb D; Sebag F; Barlier A; Tessonnier L; Palazzo FF; Morange I; Niccoli-Sire P; Fakhry N; De Micco C; Cammilleri S; Enjalbert A; Henry JF; Mundler O
    J Nucl Med; 2009 May; 50(5):711-7. PubMed ID: 19372492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-Dependent Brown Adipose Tissue Activation in Patients With Pheochromocytoma and Paraganglioma.
    Puar T; van Berkel A; Gotthardt M; Havekes B; Hermus AR; Lenders JW; van Marken Lichtenbelt WD; Xu Y; Brans B; Timmers HJ
    J Clin Endocrinol Metab; 2016 Jan; 101(1):224-32. PubMed ID: 26574955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of
    Jaiswal SK; Sarathi V; Malhotra G; Hira P; Shah R; Patil VA; Dalvi A; Prakash G; Lila AR; Shah NS; Bandgar T
    J Pediatr Endocrinol Metab; 2021 Jan; 34(1):109-119. PubMed ID: 33180042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic status determines
    Tiwari A; Shah N; Sarathi V; Malhotra G; Bakshi G; Prakash G; Khadilkar K; Pandit R; Lila A; Bandgar T
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):745-752. PubMed ID: 28585398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.
    Rischke HC; Benz MR; Wild D; Mix M; Dumont RA; Campbell D; Seufert J; Wiech T; Rössler J; Weber WA; Neumann HP
    J Nucl Med; 2012 Sep; 53(9):1352-8. PubMed ID: 22836345
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Feral CC; Tissot FS; Tosello L; Fakhry N; Sebag F; Pacak K; Taïeb D
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):812-821. PubMed ID: 27900521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.
    Chang CA; Pattison DA; Tothill RW; Kong G; Akhurst TJ; Hicks RJ; Hofman MS
    Cancer Imaging; 2016 Aug; 16(1):22. PubMed ID: 27535829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of [
    Takenaka J; Watanabe S; Abe T; Hirata K; Uchiyama Y; Kimura R; Shinohara N; Kudo K
    Ann Nucl Med; 2023 Jan; 37(1):10-17. PubMed ID: 36301465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study.
    Blanchet EM; Taieb D; Millo C; Martucci V; Chen CC; Merino M; Herscovitch P; Pacak K
    J Nucl Med; 2015 Dec; 56(12):1849-54. PubMed ID: 26359261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head-to-head comparison between [
    He Q; Zhang Z; Zhang L; Zhang B; Long Y; Zhang Y; Liao Z; Zha Z; Zhang X
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1989-2001. PubMed ID: 38300262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pheochromocytoma and Paraganglioma Patients With Poor Survival Often Show Brown Adipose Tissue Activation.
    Abdul Sater Z; Jha A; Hamimi A; Mandl A; Hartley IR; Gubbi S; Patel M; Gonzales M; Taïeb D; Civelek AC; Gharib AM; Auh S; O'Mara AE; Pacak K; Cypess AM
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1176-85. PubMed ID: 31903484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization and prediction of malignant potential in recurrent pheochromocytoma/paraganglioma (PCC/PGL) using 18F-FDG PET/CT.
    Fikri AS; Kroiss A; Ahmad AZ; Zanariah H; Lau WF; Uprimny C; Donnemiller E; Kendler D; Nordin AJ; Virgolini IJ
    Acta Radiol; 2014 Jun; 55(5):631-40. PubMed ID: 24037430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated PET/MRI With 68Ga-DOTATATE and 18F-FDG in Pheochromocytomas and Paragangliomas: An Initial Study.
    Xu S; Pan Y; Zhou J; Ju H; Zhang Y
    Clin Nucl Med; 2022 Apr; 47(4):299-304. PubMed ID: 35143455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery.
    Nockel P; El Lakis M; Gaitanidis A; Merkel R; Patel D; Nilubol N; Prodanov T; Pacak K; Kebebew E
    Ann Surg; 2019 Apr; 269(4):741-747. PubMed ID: 29334561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.